688098 申聯生物
按盤價 
12.380 -0.210 (-1.668%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.917 | -3.085 | 2.111 | 4.107 | 7.665 |
| 總資產報酬率 ROA (%) | -0.833 | -2.842 | 1.970 | 3.815 | 7.080 |
| 投入資產回報率 ROIC (%) | -0.896 | -3.043 | 2.098 | 4.079 | 7.603 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.794 | 60.249 | 70.833 | 75.229 | 75.731 |
| 營業利潤率 (%) | -13.457 | -18.625 | 11.980 | 22.896 | 35.903 |
| 息稅前利潤/營業總收入 (%) | -13.410 | -18.960 | 11.721 | 22.398 | 34.704 |
| 淨利潤/營業總收入 (%) | -12.358 | -16.067 | 9.901 | 18.556 | 29.144 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.365 | 45.936 | 85.004 | 103.279 | 90.138 |
| 價值變動淨收益/利潤總額(%) | -13.527 | -4.700 | 15.960 | 4.442 | 9.590 |
| 營業外收支淨額/利潤總額(%) | -0.716 | 0.499 | 0.403 | -0.917 | -2.148 | 償債能力分析 |
| 流動比率 (X) | 4.438 | 4.740 | 7.820 | 7.257 | 6.461 |
| 速動比率 (X) | 3.606 | 3.922 | 6.359 | 6.071 | 5.550 |
| 資產負債率 (%) | 8.315 | 8.268 | 5.453 | 6.742 | 7.850 |
| 帶息債務/全部投入資本 (%) | 1.329 | 1.436 | -0.168 | 0.018 | -0.191 |
| 股東權益/帶息債務 (%) | 7,364.631 | 6,802.656 | -59,367.630 | 540,213.360 | -51,981.356 |
| 股東權益/負債合計 (%) | 1,093.139 | 1,098.323 | 1,712.637 | 1,383.268 | 1,178.606 |
| 利息保障倍數 (X) | 279.269 | 78.353 | -38.060 | -77.237 | -78.109 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 403.321 | 317.608 | 296.208 | 204.417 | 141.782 |
| 存貨周轉天數 (天) | 343.726 | 308.764 | 464.908 | 483.748 | 361.281 |
| 備註： | 即時報價更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
